Enhanced homologous recombination mediated by lambda...

Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S476000, C435S463000, C435S468000, C435S455000, C435S254200, C435S252300, C435S320100

Reexamination Certificate

active

07144734

ABSTRACT:
Disclosed herein are methods for generating recombinant DNA molecules in cells using homologous recombination mediated by recombinases and similar proteins. The methods promote high efficiency homologous recombination in bacterial cells, and in eukaryotic cells such as mammalian cells. The methods are useful for cloning, the generation of transgenic and knockout animals, and gene replacement. The methods are also useful for subcloning large DNA fragments without the need for restriction enzymes. The methods are also useful for repairing single or multiple base mutations to wild type or creating specific mutations in the genome. Also disclosed are bacterial strains and vectors which are useful for high-efficiency homologous recombination.

REFERENCES:
patent: 5652128 (1997-07-01), Jarvik
patent: 5789166 (1998-08-01), Bauer et al.
patent: 5888732 (1999-03-01), Hartley et al.
patent: 6281000 (2001-08-01), Chartier et al.
patent: 6355412 (2002-03-01), Stewart et al.
patent: 6365408 (2002-04-01), Stemmer
patent: 6509156 (2003-01-01), Stewart et al.
patent: 6787316 (2004-09-01), Stewart et al.
patent: 2002/0013956 (2002-01-01), Borts et al.
patent: 2002/0090361 (2002-07-01), Zarling et al.
patent: 2002/0151059 (2002-10-01), Te Riele et al.
patent: WO 95/22625 (1995-08-01), None
patent: WO 99/29837 (1999-06-01), None
patent: WO 9929837 (1999-06-01), None
patent: WO 01/04288 (2001-01-01), None
patent: WO 02/14495 (2002-02-01), None
patent: WO 02/062988 (2002-08-01), None
GenBank Accession No. AAG28905, Nov. 2, 2000.
Davis et al. CTXphi contains a hybrid genome derived from tandemly integrated elements.□□ Proc Natl Acad Sci U S A. vol. 97, No. 15, pp. 8572-8577, Jul. 2000. □□
GenBank Accession No. NP—390506, Aug. 12, 2004.
Kunst et al. The complete genome sequence of the Gram-positive bacterium Bacillus subtilis. Nature, vol. 390, pp. 249-256, Nov. 1997.
GenBank Accession No. Al1733, Nov. 27, 2001.
Glaser et al. Comparative genomics of Listeria species. Science, vol. 294, pp. 849-852, Oct. 2001.
GenBank Accession No. S43799, Nov. 17, 2000.
Alonso et al. The complete nucleotide sequence and functional organization of Bacillus subtilis bacteriophage SPP1. Gene, vol. 204, pp. 201-212, 1997.
Yanez et al. Analysis of the complete nucleotide sequence of African swine fever virus. Virology. vol. 208, pp. 249-278, 1995.
Scott et al. The Pendred syndrome gene encodes a chloride-iodide transport protein. Nature Genetics, vol. 21, pp. 440-443, Apr. 1999.
Everett et al. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nature Genetics, vol. 17, pp. 411-422, Dec. 1997.
Yu et al. An efficient recombination system for chromosome engineering inEscherichia coli.□□Proc Natl Acad Sci U S A. vol. 97, No. 11, pp. 5978-5983, May 2000.
Murphy et al. Use of bacteriophage lambda recombination functions to promote gene replacement inEscherichia coli. J Bacteriol. vol. 180, No. 8, pp. 2063-2071, Apr. 1998.
1996/1997 NEB Catalog, New England Biolabs, Inc., pp. 186-188.
Muyrers et al. Rapid modification of bacterial artificial chromosomes by ET-recombination.□□Nucleic Acids Res. vol. 27, No. 6, pp. 1555-1557, Mar. 1999.
Guzman et al. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol. vol. 177, No. 14, pp. 4121-4130, Jul. 1995.
Hu et al. Mol Cell Biol. vol. 10, No. 12, pp. 6141-6151, Dec. 1990.
Lowman et al. Temperature-mediated regulation and downstream inducible selection for controlling gene expression from the bacteriophage lambda pL promoter. Gene. vol. 96, No. 1, pp. 133-136, Nov. 1990.
Leemans et al. A broad-host-range expression vector based on the pL promoter of coliphage lambda: regulated synthesis of human interleukin 2 in Erwinia and Serratia species. J Bacteriol. vol. 169, No. 5, pp. 1899-1904, May 1987.
Verma et al. Gene therapy—promises, problems and prospects. Nature. vol. 389, No. 6648, pp. 239-242, Sep. 1997.
Palu et al. In pursuit of new developments for gene therapy of human diseases. J Biotechnol. vol. 68, No. 1, pp. 1-13, Feb. 1999.
Luo et al. Synthetic DNA delivery systems. Nat Biotechnol. vol. 18, No. 1, pp. 33-37, Jan. 2000.
Edelstein et al. Gene therapy clinical trials worldwide 1989-2004-an overview. J Gene Med. vol. 6, No. 6, pp. 597-602, Jun. 2004.
Capecchi, M., “Altering the Genome by Homologous Recombination,”Science244: 1288-1292, Jun. 1989.
Cho et al., “δ-Integration of endo/exo-glucanase and β-glucosidase genes into the yeast chromosomes for direct conversion of cellulose to ethanol,”Enzyme and Microbial Technology25: 23-30, Jul. 1999.
Copeland et al., “Recombineering: a powerful new tool for mouse functional genomics,”Nat. Rev. Genet. 2: 769-779, 2001.
Court et al., “Genetic Engineering Using Homologous Recombination1,”Annu. Rev. Genet.36: 361-388, 2002.
Cox, “Recombinational DNA Repair of Damaged Replication Forks inEscherichia coli, ” Annu. Rev. Genet. 35: 53-82, 2001.
Ellis et al., “High efficiency mutagenesis, repair, and engineering of chromosomal DNA using single-stranded oligonucleotides,”Proc, Natl. Acad. Sci. USA98: 6742-6746, 2001.
Harfe and Jinks-Robertson, “Mismatch repair proteins and mitotic genome stability,”Mut. Res. 451: 151-167, 2000.
Higgins et al., “A Model for Replication Repair in Mammalian Cells,”J. Mol. Biol. 101: 417-425, 1976.
Karakousis et al., “The Beta Protein of Phage λ Binds Preferentially to an Intermediate in DNA Renaturation,”J. Mol. Biol. 276: 721-731, 1998.
Lee et al., “A highly efficientEscherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA,”Genomics73: 56-65, 2001.
Li et al., “The Beta Protein of Phage λ Promotes Strand Exchange,”J. Mol. Biol. 276: 733-744, 1998.
Maas et al., “Multicopy single-stranded DNA ofEscherichia colienhances mutation and recombination frequencies by titrating MutS protein,”Molec. Microbiol. 19: (3) 505-509, 1996.
Minuyappa et al., “The homologous recombination system of phage λ,”J. Bio. Chem, 261: 7472-7478, Jun. 1986.
Moerschell et al., “Transformation of yeast with synthetic oligonucleotides,”Proc. Natl. Acad. Sci. U.S.A. 85: 524-528, 1988.
Murphy, K.C., “Use of bacteriophage λ recombination functions to promote gene replacement inEscherichia coli,” J. Bacteriol. 180: 2063-2071, 1998.
Murphy et al., “PCR-mediated gene replacement inEscherichia coli,” Gene246: 321-330, 2000.
Muyrers, et al., “Point mutation of bacterial artificial chromosomes by ET recombination,”EMBO Rep. 1: 239-243, 2000.
Muyrers et al., “RecE/RecT and Redα/Redβ initiate double-stranded break repair by specifically interacting with their respective partners,”Genes Dev. 14: 1971-1982, 2000.
Muyrers et al., “Techniques: Recombinogenic engineering-new options for cloning and manipulating DNA,”Trends Biochem. Sci. 26: 325-331, 2001.
Muyrers et al., “Rapid modification of bacterial artificial chromosomes by ET-recombination,”Nucleic Acids Res. 27: 1555-1557, 1999.
Nistala and Sigmund, “A reliable and efficient method for deleting operational sequences in PACs and BACs,”Uncle. Acid. Res. 30: 10 e 41, 2002.
Passy et al., “Rings and filaments of β protein from bacteriophage λ suggests a superfamily of recombination proteins,”Proc. Natl. Acad. Sci. U.S.A. 96: 4279-4284, 1999.
Postow et al., “Topological challenges to DNA replication: Conformations at the fork,”Proc. Natl. Acad. Sci. USA98 (15): 8219-8226, 2001.
Poteete, “What makes the bacteriophage λ Red system useful for genetic engineering: molecular mechanism and biological function,”FEMS Microbiol. Lett. 201: 9-14, 2001.
Santucci-Darmanin et al., “The DNA mismatch-repai

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Enhanced homologous recombination mediated by lambda... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enhanced homologous recombination mediated by lambda..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced homologous recombination mediated by lambda... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3719327

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.